American Journal of Clinical Pathology · 2000 · 207 citations · 37 references
MedicinePharmaceutical AnalysisPharmacologyClinical PharmacologyDiabetologyTherapeutic Drug MonitoringBlood Glucose MonitoringContinuous Glucose MonitoringDrug Safety MonitoringGlycemic ControlGlycemic MonitoringMetabolic MonitoringDrug-laboratory Test InterferenceGlucose MonitoringGlucose Monitoring DevicesGlucose QuantificationInterferenceMedication Interference In TestingMedication Package InsertsPoint-of-care Glucose Measurement
Thirty drugs used primarily in critical care and hospital settings were tested in vitro to observe interference on glucose measurements with 6 hand-held glucose meters and a portable glucose analyzer. Paired differences of glucose measurements between drug-spiked samples and unspiked control samples were calculated to determine bias. A criterion of +/- 6 mg/dL was used as the cutoff for interference. Ascorbic acid interfered with the measurements on all glucose devices evaluated. Acetaminophen, dopamine, and mannitol interfered with glucose measurements on some devices. Dose-response relationships help assessment of drug interference in clinical use. High dosages of these drugs may be given to critically ill patients or self-administered by patients without medical supervision. Package inserts for the glucose devices may not provide adequate warning information. Hence, we recommend that clinicians choose glucose devices carefully and interpret results cautiously when glucose measurements are performed during or after drug interventions.
37
Fingerstick Glucose Determination in Shock
Suzanne H. Atkin, Amita Dasmahapatra, Michael Jaker et al. · Annals of Internal Medicine · 1991 · 191 citations
Gerald J. Kost, Huynh-Troung Vu, Judith H. Lee et al. · Critical Care Medicine · 1998 · 122 citations